Omega Healthcare Invest.

The share of Omega Healthcare Investors rose to a record high of $49.33 and is currently trading near that level, with a market capitalization of $15.37 billion. Over the past year the stock gained 40.49% and offers a dividend yield of 5.56%, with dividends paid for 24 consecutive years. For Q1 2026 the company reported revenue of $323 million, beating expectations, while earnings per share of $0.47 were slightly below forecasts. Analysts' reactions are mixed: UBS confirms » More on de.investing.com

Omega Healthcare Investors names Matthew Gourmand effective Oct. 1, 2026 as CEO; he succeeds Taylor Pickett, who is retiring after 25 years. Neal Ballew will be promoted from chief accounting officer to CFO effective Aug. 1, 2026 and replaces Bob Stephenson, who is also retiring after 25 years. The board describes the changes as the result of a multi-year succession plan; under Pickett the portfolio grew to 1,124 facilities and market capitalization rose to over $15 billion. » More on de.investing.com

Analysts from Wells Fargo, Truist and Scotiabank raised price targets on Omega Healthcare Investors while maintaining Equal Weight/Hold/Sector Perform ratings. Truist trimmed 2026–2027 normalized FFO forecasts slightly and firms caution that competition in healthcare REITs tempers near-term upside despite improving same-store NOI trends in senior housing. Omega remains focused on skilled nursing and assisted living financing, but analyst views keep the stock in a neutral stance. » More on finance.yahoo.com